Clinical trial
Continuous Post-operative Lidocaine Infusion Following Major Reconstructive Spine Surgery in the Elderly to Minimize Delirium and Opiate Use: A Randomized Control Trial
NCT05010148 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Continuous Post-operative Lidocaine Infusion Following Major Reconstructive Spine Surgery in the Elderly to Minimize Delirium and Opiate Use: A Randomized Control Trial
- Lead sponsor
- University of California, San Francisco
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 17, 2021
- Completion date
- January 16, 2026
- Enrollment
- 219 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
postoperative delirium, postoperative pain, spinal fusion